Copyright
©The Author(s) 2021.
World J Gastroenterol. Feb 14, 2021; 27(6): 487-500
Published online Feb 14, 2021. doi: 10.3748/wjg.v27.i6.487
Published online Feb 14, 2021. doi: 10.3748/wjg.v27.i6.487
Figure 2 CircVAPA promotes invasion and migration of gastric cancer cells.
A-D: SGC7901 and HGC27 cells were treated with the circVAPA shRNA or control shRNA. Cell migration and invasion were tested by transwell assay (A and B), and migration and invasion were analyzed by wound healing assay (C and D). The wound healing proportion is shown. Data are presented as the mean ± SD. bP < 0.01.
- Citation: Deng P, Sun M, Zhao WY, Hou B, Li K, Zhang T, Gu F. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis. World J Gastroenterol 2021; 27(6): 487-500
- URL: https://www.wjgnet.com/1007-9327/full/v27/i6/487.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i6.487